|
TAHIT TeleSeminar: Interpreting Informed Consent in Clinical Trials
|
Monday, February 20, 2012
|
Synopsis: Barriers of communication between investigators and research participants are affecting the informed consent process during clinical trials. The problem of barriers in communication has been identified and has resulted in alternatives to improve the quality of the medical processes. Clinical trials are part of the improvement of scientific treatments. The United States Food and Drug Administration defines Clinical trials as “carefully controlled studies that are conducted in human volunteers to answer specific health questions and are the safest method to find treatments that work in individuals and improve health”. The communications process during clinical trials manifests how well participants understand the aims and protocol procedures of a study during the informed consent process. The participation of interpreters, investigators, and bilingual family members of LEP patients in the informed consent process is imperative to making the communication understandable and in (more...)
|
|
Location: http://www.tahit.us Call-in Details will be emailed to you
|
|
Time: 7:00 PM
|
|
|
